CHMP has adopted a negative opinion on lecanemab for the EU
Go back to CHMP has adopted a negative opinion on lecanemab for the EU| BARNES GROUP, Inc. (NYSE: B) | Delayed: 47.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.00 | 52 Week High | $44.27 | |||
| Open | $47.00 | 52 Week Low | $30.07 | |||
| Day High | $47.00 | P/E | 35.88 | |||
| Day Low | $47.00 | EPS | $1.31 | |||
| Volume | 34,087 | |||||
| BIOAMBER, Inc. (NASDAQ: BIOA) | Delayed: 9.84 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.84 | 52 Week High | $8.73 | |||
| Open | $9.84 | 52 Week Low | $2.86 | |||
| Day High | $9.84 | P/E | N/A | |||
| Day Low | $9.84 | EPS | $-3.82 | |||
| Volume | 588 | |||||
